Fractional Flow Reserve Versus Angiographically Guided Management to Optimise Outcomes in Unstable Coronary Syndromes

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It enrolled 350 participants.

Also called NCT01764334

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose diagnostic
Phase
Phase 4
Enrolled
  • 350 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT01764334
Main results
  • Fractional flow reserve vs. angiography in guiding management to optimize outcomes in non-ST-segment elevation myocardial infarction: the British Heart Foundation FAMOUS-NSTEMI randomized trial European heart journal, 2015-01-07 DOI, PubMed 25179764, PMC4291317 In the PMC Open Access subset under CC BY-NC.

Courtesy of the U.S. National Library of Medicine.

Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(anticipated) (from the registry)
Countries
United Kingdom (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT01764334. Randomized; quadruple masking; primary purpose diagnostic. Start 2011-10 (registry gives no type); primary completion 2014-06 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Fractional Flow Reserve Versus Angiographically Guided Management to Optimise Outcomes in Unstable Coronary Syndromes
Acronym
FAMOUS NSTEMI
Condition
NonST Elevation Myocardial Infarction
Intervention (Device)
Fractional flow reserve
Lead sponsor
NHS National Waiting Times Centre Board (class: other)
Collaborator
British Heart Foundation (class: other)
Collaborator
Abbott Medical Devices (class: industry)
Collaborator
University of Glasgow (class: other)

Record details

Record id
cardio:ct-nct01764334
Content hash
fc5f0fc058232205e42ccad5f9f6a59948c653c0f044075b8e56d59c9f7f2fe0